v3.26.3
Consolidated Statement of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities    
Net income $ 7,157 $ 4,895
Less: Net income from discontinued operations 1,061 3,299
Net income from continuing operations 6,096 1,596
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities    
Depreciation 215 206
Amortization 483 510
Gain on deconsolidation of subsidiary (6,629) 0
Equity loss (income) of affiliated companies 397 (14)
(Gain) loss on sale of non-strategic businesses and assets (351) 29
Impairment of assets held for sale 311 15
Loss on debt extinguishment 241 0
Repositioning and other charges 133 (516)
Net payments for repositioning and other charges (119) (307)
Resideo indemnification and reimbursement agreement termination payment 0 1,590
Pension and other postretirement income (268) (164)
Pension and other postretirement benefit payments (6) (13)
Stock compensation expense 182 115
Deferred income taxes 687 (248)
Other (2) (362)
Changes in assets and liabilities, net of the effects of acquisitions and divestitures:    
Accounts receivable (546) (344)
Inventories (50) (297)
Other current assets (206) (168)
Accounts payable 44 376
Accrued liabilities 567 510
Income taxes (247) 96
Net cash provided by operating activities from continuing operations 932 2,610
Net cash (used for) provided by operating activities - discontinued operations (189) 2,594
Net cash provided by operating activities 743 5,204
Cash flows from investing activities    
Capital expenditures (369) (375)
Increase in investments (771) (1,064)
Decrease in investments 728 1,047
Receipts (payments) from settlements of derivative contracts 123 (403)
Deconsolidation of subsidiary cash (623) 0
Cash paid for acquisitions, net of cash acquired (1,763) (2,201)
Proceeds from sale of business, net of cash transferred 1,454 1,157
Net cash used for investing activities from continuing operations (1,221) (1,839)
Net cash used for investing activities from discontinued operations (252) (529)
Net cash used for investing activities (1,473) (2,368)
Cash flows from financing activities    
Proceeds from issuance of commercial paper and other short-term borrowings 12,413 19,171
Payments of commercial paper and other short-term borrowings (15,882) (16,711)
Proceeds from issuance of common stock 246 140
Proceeds from issuance of long-term debt 0 4,035
Payments of long-term debt (14,688) (1,555)
Repurchases of common stock (1,000) (3,704)
Cash dividends paid (1,816) (2,214)
Pre-separation funding 15,835 0
Spin-off cash (1,000) 0
Other (125) 198
Net cash used for financing activities (6,017) (640)
Effect of foreign exchange rate changes on cash and cash equivalents (46) 167
Net (decrease) increase in cash and cash equivalents (6,793) 2,363
Cash and cash equivalents at beginning of period 12,487 10,567
Cash and cash equivalents at end of period $ 5,694 $ 12,930